Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic

Eschewing the traditional model of financing biotech startups milestone to milestone to support a lead asset, Treeline Biosciences’ well-funded pipeline is comprised of multiple complementary programs. Select investors have supported the approach of Treeline, which said it has raised more than $1.1 billion to date. The post Startup Treeline Bio Emerges From the Shadows With…

Read More

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnology with electronics comes with on-board sensors that enable clinicians to monitor and control an implant’s drug production process. The post This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’ appeared first…

Read More

Emergency Contraception

This fact sheet reviews current national and state policies around Emergency Contraception, including methods, patient awareness, access and availability, and insurance coverage. Among methods discussed are ulipristal acetate (ella), intrauterine devices (copper IUDs and levonorgestrel IUDs), and progestin-based pills (Plan B and Next Choice).

Read More

Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease

Fortitude Biomedicines is developing antibody drug conjugates that use targeted protein degraders as their therapeutic payloads. The startup joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer. The post Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease appeared first on MedCity…

Read More